2014 ICD-9-CM Diagnosis Code 425.3
- Short description: Endocard fibroelastosis.
- ICD-9-CM 425.3 will be replaced by an equivalent ICD-10-CM code (or codes) when the United States transitions from ICD-9-CM to ICD-10-CM on October 1, 2015.
- ICD-9-CM 425.3 is a billable medical code that can be used to specify a diagnosis on a reimbursement claim.
- Cardiomyopathy restrictive, endocardial fibroelastosis
- Cardiomyopathy, restrictive, due to endocardial fibroelastosis
- Endocardial fibroelastosis, congenital
- Primary endocardial fibroelastosis
- Primary endocardial fibroelastosis (heart condition)
- Restrictive cardiomyopathy secondary to endocardial fibroelastosis
- A condition characterized by the thickening of endocardium due to proliferation of fibrous and elastic tissue, usually in the left ventricle leading to impaired cardiac function (cardiomyopathy, restrictive). It is most commonly seen in young children and rarely in adults. It is often associated with congenital heart anomalies (heart defects congenital;) infection; or gene mutation. Defects in the tafazzin protein, encoded by taz gene, result in a form of autosomal dominant familial endocardial fibroelastosis.
- A rare disorder characterized by diffuse thickening of the endocardium. It presents with unexplained heart failure.
- Condition characterized by hypertrophy of the wall of the left ventricle and conversion of the endocardium into a thick fibroelastic coat, with the capacity of the ventricle sometimes reduced, but often increased.
Convert to ICD-10-CM
converts directly to:
- 2014 ICD-10-CM I42.4 Endocardial fibroelastosis